buyWeak

Susan C Schnabel bought $117k of VRAY

director at ViewRay, Inc.. 25,000 shares at an average of $4.70, traded Nov 28, 2022, filed Nov 29, 2022.

Conviction score

Value

$117k

25,000 shares

Holdings after

192,790

+15% from before

From 52-week low

no price yet

From 52-week high

no price yet

Score components

Role
Director
+15
Trade size
$117k at market
+10
Relative to holdings
Holdings up 15%
+3
Price context
No price history yet
0
Cluster
No other insider buying within 14 days
0
Repeat buying
First buy in 90 days
0
Track record
Too few past buys to judge (2 with prices)
0

What happened after comparable buys

Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.

Rows in this filing

Every transaction in Form 4 0001628280-22-030933, as filed. Open on EDGAR

Date	Transaction	Shares	Price	Value	Holdings after	Filed
Nov 28, 2022	POpen-market purchase Common Stock	+11,366	$4.71	$54k	179,156	Nov 29, 2022
Nov 28, 2022	POpen-market purchase Common Stock	+500	$4.68	$2,340	179,656	Nov 29, 2022
Nov 28, 2022	POpen-market purchase Common Stock	+1,665	$4.69	$7,809	181,321	Nov 29, 2022
Nov 28, 2022	POpen-market purchase Common Stock	+2,531	$4.70	$12k	183,852	Nov 29, 2022
Nov 28, 2022	POpen-market purchase Common Stock	+8,638	$4.68	$40k	192,490	Nov 29, 2022
Nov 28, 2022	POpen-market purchase Common Stock	+100	$4.70	$470	192,590	Nov 29, 2022
Nov 28, 2022	POpen-market purchase Common Stock	+200	$4.68	$936	192,790	Nov 29, 2022

Related signals

Other insiders at ViewRay, Inc. and this insider’s other filings.

Score	Company	Insider	Value	Holdings	Filed
11Weak	VRAYsell ViewRay, Inc.	James F. Dempsey Chief Scientific Officer	$173k 42,000 shares	-6%	Mar 21, 2023

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.